Zivanovic, Oliver

Publications

Sort by

Co-Author Network

selected publications

Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 5
Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 9
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 16
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 152
Evolution and outcomes of sentinel lymph node mapping in vulvar cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Academic Article GET IT
Times cited: 18
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of gynecologic oncology. 2020 Academic Article GET IT
Times cited: 17
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecologic oncology. 2019 Academic Article GET IT
Times cited: 44
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program. JAMA oncology. 2019 Academic Article GET IT
Times cited: 8
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer. Gynecologic oncology. 2018 Academic Article GET IT
Times cited: 13
It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer. Gynecologic oncology. 2018 Review GET IT
Times cited: 28
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?. Gynecologic oncology. 2018 Academic Article GET IT
Times cited: 50
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study. Cancer medicine. 2018 Academic Article GET IT
Times cited: 16
Trocar site hernia development in patients undergoing robotically assisted or standard laparoscopic staging surgery for endometrial cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 3
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 32
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. 2017 GET IT
Times cited: 317
Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2017 Review GET IT
Times cited: 38
Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 24
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 26
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2017 Academic Article GET IT
Times cited: 37
Risk-reducing salpingectomy: Let us be opportunistic. Cancer. 2017 Review GET IT
Times cited: 22
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 35
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 54
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 87
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 17
Early diagnosis of genital mucosal melanoma: how good are our dermoscopic criteria?. Dermatology practical & conceptual. 2016 Academic Article GET IT
Times cited: 61
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family. 2016 GET IT
Times cited: 12
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 70
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 11
Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 34
Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. Gynecologic oncology. 2016 Academic Article GET IT
Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 35
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 3
Introducing Hyperthermic Intraperitoneal Chemotherapy into Gynecological Oncology Practice - Feasibility and Safety Considerations: Single-Center Experience. Oncology research and treatment. 2016 Academic Article GET IT
Times cited: 2
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery. Annals of surgical oncology. 2016 Academic Article GET IT
Times cited: 66
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 95
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 8
Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer. Annals of surgical oncology. 2016 Academic Article GET IT
Times cited: 28
Is It Time to Centralize Ovarian Cancer Care in the United States?. Annals of surgical oncology. 2015 Review GET IT
Times cited: 43
Intraoperative Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer. Oncology (Williston Park, N.Y.). 2015 Review GET IT
Times cited: 8
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer. Gynecologic oncology. 2015 Academic Article GET IT
Times cited: 65
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping. Annals of surgical oncology. 2015 Academic Article GET IT
Times cited: 76
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2015 Academic Article GET IT
Times cited: 13
Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma. Gynecologic oncology. 2014 Academic Article GET IT
Times cited: 73
A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecologic oncology. 2014 Academic Article GET IT
Times cited: 9
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. International journal of cancer. 2014 Academic Article GET IT
Times cited: 70
Cytoreductive surgery for advanced ovarian cancer. Women's health (London, England). 2014 Review GET IT
Times cited: 15
Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 12
Interval debulking surgery in patients with Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV ovarian cancer. Onkologie. 2013 Academic Article GET IT
Times cited: 16
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer. 2013 Academic Article GET IT
Times cited: 51
Pharmaceutical care for patients with breast and ovarian cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2012 Academic Article GET IT
Times cited: 36
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer. Obstetrics and gynecology. 2012 Academic Article GET IT
Times cited: 32
Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 51
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 50
"Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas. The American journal of surgical pathology. 2011 Academic Article GET IT
Times cited: 41
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 32
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT). Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 222
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer. 2011 Academic Article GET IT
Times cited: 112
Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. The American journal of surgical pathology. 2011 Academic Article GET IT
Times cited: 176
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 153
Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 43
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 60
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 34
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 126
A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. Gynecologic oncology. 2009 Review GET IT
Times cited: 52
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 22
Advanced cytoreductive surgery: American perspective. Gynecologic oncology. 2009 Review GET IT
Times cited: 34
Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer. The oncologist. 2009 Review GET IT
Times cited: 35
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 479
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 111
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 72
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 125
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 142
Retroperitoneal lymph node dissection (RPLND). Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 11
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 37
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 163
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up. Cancer. 2008 Academic Article GET IT
Times cited: 3
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 98
Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast cancer research and treatment. 2007 Academic Article GET IT
Times cited: 61
Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer. 2007 GET IT
Times cited: 65
Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology. 2006 Academic Article GET IT
Times cited: 150
MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time. European radiology. 2005 Academic Article GET IT
Times cited: 42
Patients with malignancy requiring urgent therapy: CASE 1. Central airway obstruction as first presentation of ovarian cancer. 2005 GET IT
In search for predictive factors for atopy in human cord blood. Allergy. 2005 Review GET IT
Times cited: 31
[The impact of the pathologist on the treatment of epithelial ovarial cancer]. Verhandlungen der Deutschen Gesellschaft fur Pathologie. 2005 Review GET IT
Times cited: 2
3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences. European radiology. 2004 Academic Article GET IT
Times cited: 45
The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach. International journal of oncology. 2004 Academic Article GET IT
Times cited: 17

more ...

less ...

Background

education and training

M.D., Johannes Gutenberg University, Faculty of Medicine (Germany) 2000

Contact

full name

Oliver Zivanovic

VIVO Weill Cornell Medical College

Oliver Zivanovic Assistant Professor of Obstetrics and Gynecology

Publications

selected publications

Background

education and training

Contact

full name